Search results
Will we really die from minor scratches in the future? Q&A with antibiotic resistance expert
Medical Xpress· 45 minutes agoThe Conversation spoke to James P. O'Gara, a professor of microbiology, about the problem of...
Ascendiant Capital highlights cancer therapy, sees potential on RenovoRx stock By Investing.com
Investing.com· 9 hours agoOn Monday, Ascendiant Capital initiated coverage on RenovoRx Inc. (NASDAQ:RNXT) stock with a Buy...
Insider Sale: SVP, Chief Technology Officer Silji Abraham Sells Shares of West Pharmaceutical ... By...
Investing.com· 4 days agoThe transaction was reported in a recent SEC Filing. Following this transaction, the insider now...
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word. | The Motley...
The Motley Fool· 1 day agoIf you're eyeing an investment in Madrigal Pharmaceuticals (MDGL 0.04%), now's the time to imagine a representative of Eli Lilly (LLY 0.64%) interrupting your train of...saying ...
Raya’s pipeline ALS drug shows early signs of efficacy in Phase II trial
Clinical Trials Arena via Yahoo Finance· 6 hours agoRaya Therapeutics said that it will initiate more amyotrophic lateral sclerosis (ALS) trials in 2025...
Firm grows local presence with $10M upgrade to drug testing facility - Baltimore Business Journal
The Business Journals· 4 days agoAn international pharmaceutical company has invested $10 million into upgrades at a Baltimore...
Mounjaro Is Targeting Another Multibillion-Dollar Market: Is Eli Lilly Stock a Buy?
Motley Fool via Yahoo Finance· 2 days agoIn fact, the U.S. Food and Drug Administration approved the first medicine for NASH just this year....
Cranbury Pharmaceuticals Receives FDA Approval for First Generic Version of Emflaza Oral Suspension
New Jersey Business Magazine· 4 days agoCranbury Pharmaceuticals, a wholly-owned subsidiary of Tris Pharma, today announced the U.S. Food...
Balancing AI-Powered Drug Discovery’s Risk and Reward | JD Supra
JD Supra· 3 days agoPatenting drugs discovered with AI assistance requires that a human made significant contribution to the invention—this article contains several examples. Startups must plan carefully, while ...
CNS Pharmaceuticals secures $1.37 million in offering By Investing.com
Investing.com· 3 days agoCNS Pharmaceuticals, Inc. (NASDAQ:CNSP), a biopharmaceutical company focusing on brain and central...